We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Plavix Patent Protected by Supreme Court Denial
Plavix Patent Protected by Supreme Court Denial
November 6, 2009
The Supreme Court denial of Apotex’s petition challenging a patent on Sanofi Aventis and Bristol-Myers Squibb’s (BMS) blood-thinner drug Plavix protects a patent on the drug that Apotex had contended was not strong enough to maintain validity.